Funding information
pain medications than those with IVPCA (P < 0.001). There was no major effect of epidural analgesia on time to ambulation or complications (all P > 0.05). After adjusting for perioperative factors, and surgical extent and approach, no significant differences in fluids administered or length of stay were detected.
CONCLUSIONS: Overall postoperative outcomes were not significantly different based on method of analgesia after adjusting for type and extent of hepatic resection. Though patients with epidurals underwent more extensive operations they required less additional IV pain medications than IVPCA patients.
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Epidural analgesia is routinely used at many institutions to provide postoperative pain control for patients undergoing major abdominal surgery. Although epidural analgesia has often been considered the gold standard for postoperative pain control, there is conflicting data regarding surgical outcomes and complications related to epidural analgesia. Previous studies have indicated that epidural use improves surgical outcomes by inhibiting the surgical stress response and thus reduces rates of postoperative cardiac complications, thromboembolism, and respiratory distress.
1,2 Epidural anesthesia has also been associated with earlier return of bowel function 2 and superior pain control compared to parenteral opioids. 3, 4 However, there is limited data regarding the efficacy of epidurals in oncology patients undergoing complex hepatobiliary surgeries. Hepatectomy patients in particular may be at risk for complications due to coagulopathy, 5 yet other studies have concluded that there is no significant difference between epidural and intravenous (IV) patient-controlled analgesia rates of complications and overall morbidity and mortality. 6 Because of the limited and conflicting data regarding pain outcomes in patients undergoing liver resection, we conducted a retrospective study of hepatectomy patients at our institution over a 2-year period to assess pain control, fluid administration, length of stay, and surgical complications. We compared patients who received thoracic epidural analgesia (TEA) to those who received intravenous patient-controlled analgesia (IVPCA). We hypothesized that TEA would prove superior to IV PCA in terms of pain control and postoperative complications. Patient characteristics were summarized using frequencies and percentages or medians and ranges. Demographic information and surgical characteristics were compared by method of postoperative pain control using Chi-squared tests. Pain scores at 6, 12, 24, and 48 h were compared by receipt of a TEA using ANOVA. Next, the total number of fluids (mL) and length of stay (days) was compared using ANOVA by method of post-operative pain control and, if a TEA was administered, by functional TEAs and by intraoperative TEA infusion.
| MATERIALS AND METHODS
In patients who received a TEA, univariate logistic regression was used to assess odds of functional TEA and hypotension. (Table 1) . Of the 53 patients who had TEA, 7.5% (n = 4) had delayed removal of the catheter due to coagulopathy or low platelet count.
Excluding patients with chronic pain, there was no statistically significant difference in NRS pain scores at 12, 24, and 48 h postoperatively between the TEA and IVPCA groups, but a significant difference in NRS pain scores at 6 h postoperatively (mean pain score was 3.23 in patients without TEA vs. 1.95 in patients with TEA, P = 0.046) was detected. However, after adjustment for perioperative factors, there was no significant difference in mean pain scores at all time points (Table 2) .
Vasopressor infusion and the presence of a TEA were associated with higher amounts of perioperative fluid administration (P = 0.021 and 0.014, respectively; Table 2 ).
Patients with TEA had significantly longer hospital stays than those with IVPCA (median 6 days vs. 4 days, P = 0.039; Table 2 
| DISCUSSION
Although epidural analgesia has been shown to be beneficial in many types of abdominal surgeries, there is special concern for its use in hepatectomy patients due to complications related to coagulopathy and increased transfusion requirements. have recommended the use of regional anesthesia and NSAIDs for pain control in hepatectomy patients to limit opioid requirements, decreasing their negative potential immunomodulatory effects. 15 These potential benefits of epidural analgesia must be weighed against the theoretical risks of coagulopathy and increased transfusion in hepatectomy patients.
The selection of pain control method for the patients in our study
was not based on a standardized pain management protocol. The decision of whether to administer a TEA or IV PCA for postoperative pain control was made at the discretion of the operative surgeon.
None of the patients in our study developed TEA hematomas or abscesses, although 7.5% had delayed catheter removal due to changes in coagulation profiles. These results are in agreement from a study by Elterman and Xiong, 8 indicating that epidural analgesia can be safe in patients undergoing liver resection.
Of the 60% of patients in our study who had TEA for postoperative pain control, 13% had nonfunctional TEAs and 25% experienced hypotension. We attempted to identify specific factors that were predictors of nonfunctional TEAs and hypotension by performing a univariate analysis, but the only significant finding was an ECOG performance status of two. As this was not the primary objective the study, the study was likely underpowered for this specific analysis.
Our data indicate that there is no significant difference in pain scores between patients who received TEA and those who received IVPCA for postoperative pain control after adjusting for confounding factors. This was true among patients with or without chronic pain.
After infiltration in hepatectomy patients. 16 They found that patients in the epidural group had lower pain scores in the first 48 h after surgery both at rest and with movement. However, there was no difference in complication rates or time to first mobilization. There was no difference in overall Clavien-Dindo complication grade between TEA patients and IVPCA patients in our study. These results are in agreement with those in the prospective study by Revie et al. 16 The limitations of this study are a small sample size and lack of a standardized protocol for management of TEA in hepatectomy patients. In addition, there was selection bias in choosing patients for TEA versus IVPCA. Patients with more extensive surgeries tended to be selected for TEA. Furthermore, the pain scores did not account for the specific quantities of pain medication or intraoperative local anesthetic administered. In addition, we feel that a cost analysis of IV PCA versus epidural would be beneficial in future
studies. An advantage of this study was the ability to collect a substantial amount of data on postoperative outcomes and perioperative pain scores. Collaboration with the anesthesiology pain service faculty allowed the extraction and interpretation of intraoperative data. Patients with TEA also had a lower requirement for additional IV pain medications than patients with IVPCA alone. These results suggest that epidural analgesia can be a safe and effective method of perioperative pain control in patients undergoing liver resection. A prospective study is necessary to further explore the use of epidural analgesia in hepatectomy patients, as well as a cost analysis.
